Media mentions

<p>Institute for Bioengineering of Catalonia (IBEC). Image: IBEC.</p>
26 Jun 2017 - El Punt AVUI

Several media have echoed the expansion of the Barcelona Institute of Science and Technology (BIST) Foundation with the incorporation of the Institute for Bioengineering of Catalonia (IBEC).

Approved by the BIST Board of Trustees, chaired by Andreu Mas-Colell, the incorporation of IBEC implies that the BIST Community now comprises 2,347 people from 7 centres, including IRB Barcelona.

Link to El Punt Avui

Selected media mentions

Link to ...

<p>Super computer MareNostrum, (BSC-CNS). Image: La Vanguardia.</p>
26 Jun 2017 - La Vanguardia

La Vanguardia devotes an extensive report to research conducted in Barcelona, the metropolitan area of which has become the most important scientific capital of the Mediterranean, together with Israel, within the last 25 years.

The report includes the testimony of Gemma Turon, PhD student with the Colorectal Cancer laboratory at IRB Barcelona, who has already published a paper as a co-first author in the EMBO Molecular Medicine journal. "There are now more opportunities, better prospects and more resources and excellence has stopped being an exception," La Vanguardia emphasizes.

Link to...

<p>Andreu Mas-Colell, BIST Founding Conference, 2017. Image: BIST.</p>
24 Jun 2017 - La Vanguardia

“La Vanguardia” publishes the interview of the Efe Agency with Andreu Mas-Colell, president of the Barcelona Institute of Science and Technology (BIST). Since 2015, the BIST has brought together six of the main Catalan research centres, including IRB Barcelona.

During the interview, Mas-Colell gives a positive evaluation of his first year at the helm of BIST, highlighting the € 10 million funding achieved from the European Marie Curie Programme. This funding will allow 89 researchers to work in the six Catalan centres from September 2017 to 2022. "The juxtaposition of the six research centres allows us to have a collective identity of presence in the world and to exploit economies...

<p>Manuel Serrano, group leader of the Cellular Plasticity and Disease laboratory at IRB Barcelona.</p>
23 Jun 2017 - Cadena Ser

'El Balcó', a programme on Cadena SER radio, interviews Manuel Serrano, group leader of the Cellular Plasticity and Disease laboratory at IRB Barcelona. During the interview, the ICREA researcher explains what his goals are in regenerative medicine.

"Regenerative medicine seeks to generate new cells. For example, in diabetes, the pancreas lacks cells that produce insulin. What we are trying to do is to generate cellular plasticity in the cells of the pancreas so that they are able to generate cells that produce insulin," explains Manuel Serrano.

Access the full...

<p>Manuel Serrano, group leader of the Cellular Plasticity and Disease laboratory at IRB Barcelona.</p>
19 Jun 2017 - La Vanguardia

The newspaper “La Vanguardia” interviews Manuel Serrano, group leader of the Cellular Plasticity and Disease Lab, on the occasion of his recent incorporation to IRB Barcelona thanks to the ICREA programme and the Obra Social "la Caixa". In the interview, the ICREA researcher explains the reasons that have led him to make the leap from cancer to regenerative medicine and to choose the Institute to continue his career.

"Biology is an endless quest, and the questions I ask myself are very different from the ones I asked myself when I started, but you realize that even though we have advanced a lot, our knowledge stills very incomplete," says Manuel Serrano. 

 

16 Jun 2017 - Regió 7 & Other media

Several media have echoed the election of Núria López-Bigas, ICREA Research Professor and group leader of the Biomedical Genomics Lab at IRB Barcelona, as European Molecular Biology Organization (EMBO) Member.

EMBO has announced the membership of 65 new outstanding life scientists—these joining a group of more than 1700 of the best researchers in Europe and around the world.

Link to Regió 7

Selected Media Mentions

Link to ...

<p>Image: Worldwide Cancer Research.</p>
16 Jun 2017 - Worldwide Cancer Research

The leading UK charity funding research into cancer, Worldwide Cancer Research, devotes a report to Salvador Aznar-Benitah's work on two new proteins that, when faulty, can allow cancer to develop. 

Published in the journal eLife, the study reports a key role for the Dnmt3a and Dnmt3b proteins in protecting cells from cancer.

Link to Worldwide Cancer Research

<p>Eduard Batlle.</p>
13 Jun 2017 - ARA & La Vanguardia

The newspaper "ARA" reports on the award of the XI Francisco Cobos Foundation Prize for Excellence in Biomedical Research to ICREA researcher Eduard Batlle, coordinator of the Oncology Programme and head of the Colorectal Cancer Laboratory at IRB Barcelona.

The article also includes the jury's acknowledgment of his contribution to knowledge of colorectal cancer and the potential of his research to generate new treatments and diagnostic tools for this disease.

Selected Media Mentions 

Link to Diari ARA

Link to...

<p>Salvador Aznar Benitah.</p>
13 Jun 2017 - Heraldo de Soria

The Fundación Científica Caja Rural de Soria (FCCR) presents Salvador Aznar Benitah with a prize for his research on cancer. This award is given in recognition of the "exceptional work" done by the ICREA researcher and group leader of the Stem Cells and Cancer Lab at IRB Barcelona.

As part of the award, Salvador Aznar Benitah will be presenting his findings in metastasis research in the opening session of the Soria Health Congress 2017, on October 19.

12 Jun 2017 - La poma de Newton

The radio programme "La Poma de Newton" on science, research and innovation, broadcasted by Catalunya Informació and presented by Purificación Barceló, echoes on the study led by ICREA researcher Salvador Aznar Benitah, Group leader of the Stem Cells and Cancer Laboratory at IRB Barcelona. This study identifies the cells responsible for initiating and promoting metastasis in several types of human tumours.

"When the tumours of patients that have been identified to be predisposed toward developing metastasis are stimulated with a high-fat diet or high levels of palmitic acid, they become more aggressive. Depending on the patient, a tumour is 10 or 15 times more metastatic when fed...